
Novo Nordisk Receives FDA Approval for Higher-Dose Wegovy® (Semaglutide) Injection
FDA Fast-Tracks 7.2 mg Dose for Enhanced Weight Loss and Long-Term Weight Management Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA)

FDA Fast-Tracks 7.2 mg Dose for Enhanced Weight Loss and Long-Term Weight Management Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA)